An HPB Commemoration: Nancy E. Kemeny, MD Celebratory Symposium — On Demand

Friday, December 29, 2023, 9:00 AM - Monday, September 30, 2024, 11:00 PM

The Memorial Sloan Kettering HPB Commemoration was a three-part event held live, in-person on November 30 through December 2, 2023, highlighting the remarkable progress made in the management of patients with HPB malignancies over recent years, resulting in enhanced outcomes and prolonged survival. The event honored the legacy of Dr. Leslie H. Blumgart, celebrated the remarkable career of Dr. Nancy E. Kemeny, and delivered a comprehensive update on the latest developments from the David M. Rubenstein Center for Pancreatic Cancer Research. We are delighted to extend an on demand option for the Nancy E. Kemeny, MD Celebratory Symposium as well as the Pancreas Cancer Center Progress Update.

Nancy E. Kemeny, MD has devoted her career to the treatment of patients with metastatic colorectal cancer and has almost single-handedly established a critical role for regional intrahepatic (HAI) chemotherapy, both in the adjuvant and advanced setting. This therapy was initially not widely accepted outside of MSK, but its efficacy has since been demonstrated and it is now used widely throughout North America and beyond. Its role in other diseases, specifically intrahepatic cholangiocarcinoma, is under active investigation.

The program includes a keynote presentation by Dr. Kemeny on the history and present use of locoregional therapy for liver metastases. The program will consist of state-of-the-art didactic sessions and case presentations on the biology of liver metastases, rationale and types of locoregional approaches as well as the future of HAI therapy.

On Demand Content

In purchasing this on demand, you'll receive access to video recordings, PDFs of the speakers' presentations (slides), and recorded Q&A/panel discussions for the following sessions topics:

• Keynote Address
  • Hepatic Arterial Therapy: The Past, Present and Future (Nancy E. Kemeny, MD)
• Locoregional and Systemic Therapy for Liver Metastases  
  • Systemic Therapy for mCRC 
  • HAI for Unresectable Liver Metastasis 
  • Systemic Therapy for Cholangiocarcinoma 
  • HAI for Unresectable Intrahepatic Cholangiocarcinoma 
  • y 90/Chemoembolization in mCRC 
  • Radiation to mCRC Liver Metastases
• Biology of Liver Metastases  
  • Liver Trophism
  • Immunogenicity in Liver Metastases 
  • Liver Transplant for mCRC
  • Innovation in Liver Resection 
• Future of HAI Therapy 
  • Novel Agents
  • Development of HAI Consortium
  • International HAI Program: The Netherlands 
  • Current HAI Trials 
• Multidisciplinary Case Presentations 

Target Audience

The content featured in this on demand is intended for medical and surgical oncologists, gastroenterologists, internal medicine specialists, pathologists, geneticists, pharmacists, supportive care staff, advanced practice practitioners, nurses, trainees, and other disciplines.

1. Summarize the evolving role of liver resection for managing hepatic malignancy
2. Discuss the role of regional chemotherapy in the management of metastatic and primary liver cancer
3. Implement recent advances in pancreatic cancer research

Upon successful registration, access to the course materials, including instructions for claiming credit, is located under the 'Course Content' tab. This on demand program will be available for purchase until June 30, 2024. For those that purchase this on demand, access to the content, as well as the opportunity to claim credit, is available through September 30, 2024.

On Demand Access Fees

• Physicians (MDs, PhDs, and DOs): $175
• Advanced Practice Providers: $125
• Pharmacists, Nurses, and Other Healthcare Providers: $100
• Residents and Resident: complimentary*
• MSK Employees: complimentary

*Residents and Fellows: Registration is required in order to access this on demand program. Please submit your request here for a complimentary promotion code to be applied during registration.

MSK Alumni and MSK Cancer Alliance Members: A discounted registration rate is offered to MSK Alumni and MSK Cancer Alliance members for all MSK CME programs. If you belong to either of these groups, please submit your request here to receive a promotion code to be applied at registration. Please note that after your payment has been processed, no further promotional discounts or adjustments will be made to your registration.

MSK Employees: MSK employees can register for any CME program on a complimentary basis. Employees need to log in to the MSK CME Portal using their SS0 login credentials and register for the desired program.  

This Memorial Sloan Kettering Continuing Medical Education on demand program is non-refundable.

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement

Memorial Sloan Kettering Cancer Center designates this enduring material for a maximum of 7.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Recorded/Review Date: December 1, 2023 | Original Release Date: December 29, 2023 | Termination Date: September 30, 2024

MSK Symposium Directors 

William R. Jarnagin, MD, FACS
Leslie Blumgart Chair in Surgery
Chief, Hepatopancreatobiliary Service
Department of Surgery 

Andrea Cercek, MD
Section Head, Colorectal Cancer
Co-Director, Center for Young Onset Colorectal and Gastrointestinal Cancers
Associate Attending
Gastrointestinal Oncology Service
Department of Medicine

Michael I. D'Angelica, MD, FACS
Attending 
Hepatopancreatobiliary Service
Department of Surgery 

Christine A. Iacobuzio-Donahue, MD, PhD
Director, David M. Rubenstein Center for Pancreatic Cancer Research
Attending
Department of Pathology

Yelena Y. Janjigian, MD
Chief, Gastrointestinal Oncology Service
Department of Medicine

T. Peter Kingham, MD, FACS
Director, Global Cancer Disparities Initiatives
Attending
Hepatopancreatobiliary Service
Department of Surgery 

Eileen M. O’Reilly, MD
Winthrop Rockefeller Endowed Chair in Medical Oncology
Section Head, Hepatopancreaticobiliary and Neuroendocrine Cancers
Co-Director of Medical Initiatives, David M. Rubenstein Center for Pancreatic Cancer
Attending, Member
Department of Medicine 
Professor of Medicine, Weill Cornell Medical College

 

Invited Faculty

Karen Brown, MD
Clinical Professor
Interventional Radiology Service
Weil Cornell Medical College
New York, NY

Bas Groot Koerkamp, MD, PhD
Professor of Surgery
Epidemiologist
HPB and Transplant Division
Erasmus University Medical Center 
Rotterdam, South-Holland, The Netherlands

Jonathan Hernandez, MD
Chief, Surgical Oncology Section
Associate Professor of Surgery 
National Cancer Institute (NCI) / National Institutes of Health (NIH)
Bethesda, MD

Michael Lidsky, MD
Associate Professor
Surgical Oncology Service 
Duke Health 
Durham, NC

Shishir Maithel, MD
Professor of Surgery
Winship Cancer Institute
Emory University
Atlanta, GA

Richard Schulick, MD, MBA
Director of Cancer Center
Chair of the Department of Surgery
University of Colorado School of Medicine
Aurora, CO

Jean Nicolas Vauthey, MD
Professor of Surgery
MD Anderson Cancer Center 
Houston, TX

 

MSK Faculty 

Alex Blair, MD
Fellow
Hepatopancreatobiliary Service
Department of Surgery

Louise Catherine Connell, MB, BCH, BAO, BMedSc
Assistant Attending 
Gastrointestinal Oncology Service
Department of Medicine 

Christopher Crane, MD
Attending
Department of Radiation Oncology

Michael I. D'Angelica, MD, FACS
Attending 
Hepatopancreatobiliary Service
Department of Surgery 

Richard Kinh Gian Do, MD, PhD
Attending
Body Imaging Service 
Department of Radiology
Professor of Radiology, Weill Cornell Medical College

Karuna Ganesh, MD, PhD
Assistant Member, Assistant Attending
Molecular Pharmacology Program and Gastrointestinal Oncology Service

James J. Harding, MD
Assistant Attending
Gastrointestinal Oncology and Early Drug Development Service
Department of Medicine 
Assistant Professor of Medicine, Weill Cornell Medical College

William R. Jarnagin, MD, FACS
Leslie Blumgart Chair in Surgery
Chief, Hepatopancreatobiliary Service
Department of Surgery 

Nancy Kemeny, MD, FACSO
Attending
Gastrointestinal Oncology Service
Department of Medicine
Professor of Medicine, Weill Cornell Medical College

T. Peter Kingham, MD, FACS
Director, Global Cancer Disparities Initiatives
Attending
Hepatopancreatobiliary Service
Department of Surgery 

Philip B. Paty, MD
Attending Surgeon
Talcott Chair for Clinical Excellence 
Colorectal Service
Department of Surgery

Devika Rao, MD, FACP
Assistant Attending
Medical Site Director - MSK Basking Ridge
Department of Medicine 

Diane Reidy-Lagunes, MD
Associate Attending, Vice Chair 
Gastrointestinal Oncology Service
Department of Medicine

Mark A. Schattner, MD, FASGE, AGAF
Chief, Gastroenterology, Hepatology 
and Nutrition Service 
Professor of Clinical Medicine, Weill Cornell College of Medicine 

Neil H. Segal, MD, PhD
Associate Attending
Research Director
Gastrointestinal Oncology Service 
Department of Medicine

Kevin C. Soares, MD, MSc
Assistant Attending
Hepatopancreatobiliary Service 
Department of Surgery

Constantinos T. Sofocleous, MD, PhD
Attending
Interventional Radiology 
Department of Radiology
Professor of Radiology, Weill Cornell College of Medicine 

Alice Wei, MD, MSc, FRCSC, FACS
Attending Surgeon
Hepatopancreatobiliary Service 
Department of Surgery 
Associate Professor of Surgery, 
Weill-Cornell School of Medicine

Rona Yaeger, MD
Associate Attending
Gastrointestinal Oncology Service 
Department of Medicine

 

Link to Faculty Disclosures 

 

Mitigation of Relevant Financial Relationships

Memorial Sloan Kettering Cancer Center adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. 
In accordance with the ACCME's Standards, identification, mitigation and/or disclosure of financial relationships is not needed for non-clinical accredited education.